Pharmalundensis shares have been suspended from trading on the Copenhagen Stock Exchange following a dramatic, company-facilitated rally that pushed the stock price from DKK 3.50 to DKK 1,000.
The exchange has imposed an indefinite trading halt as the company prepares for delisting, scheduled for next Wednesday.
The suspension comes after the company issued a press release that effectively hyped the stock, creating a final window for investors to buy before the listing ends.
The move has drawn sharp criticism from market observers, including CNBC’s Jim Cramer, who warned that the parabolic price action has completely detached from the company’s underlying fundamentals.
The episode highlights the risks associated with low-liquidity, small-cap equities on the Nordic exchanges, where limited oversight and low trading volumes can allow for extreme price manipulation.
With 142 listed companies on the Copenhagen exchange, many operate with minimal visibility, making them susceptible to such speculative bubbles.